Detalles de la búsqueda
1.
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.
J Viral Hepat
; 24(4): 280-286, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27935166
2.
Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjects.
J Viral Hepat
; 23(2): 96-104, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26436610
Resultados
1 -
2
de 2
1
Próxima >
>>